Avantor (NYSE: AVTR)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.360 | 0.380 | 0.0200 | ||||
REV | 1.930B | 1.950B | 20.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Avantor (NYSE: AVTR) through any online brokerage.
Other companies in Avantor’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Avantor (NYSE: AVTR) was reported by Morgan Stanley on Monday, May 2, 2022. The analyst firm set a price target for 40.00 expecting AVTR to rise to within 12 months (a possible 26.70% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Avantor (NYSE: AVTR) is $31.57 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Avantor.
Avantor’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Avantor.
Avantor is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.